We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CORIXA GETS FDA WARNING LETTER FOR BEXXAR PROMOTION
CORIXA GETS FDA WARNING LETTER FOR BEXXAR PROMOTION
March 26, 2004
The FDA has told Corixa to stop distributing a promotional video for its combination cancer treatment and provide the agency’s Division of Drug Marketing, Advertising and Communications (DDMAC) with a plan of action to correct misleading safety and efficacy claims made in the material.